Skip to main content
ICU logo

ICU · SeaStar Medical Holding Corp

$3.77 +0.03 (+0.80%) At close · Jul 24
Market Cap
$14.99M
Shares
4.00M

SeaStar Medical Holding Corp Earnings Call Transcripts

Every quarterly earnings call for SeaStar Medical Holding Corp (ICU) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-06-30
SeaStar Medical Holding Corp Q2 FY2026 Earnings Call
Confident tone QUELIMMUNE pediatric commercial adoption NEUTRALIZE-AKI pivotal trial enrollment Adult AKI market opportunity and FDA pathway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
SeaStar Medical Holding Corp Q1 FY2026 Earnings Call
Confident tone Quellimmune pediatric commercial momentum Neutralize AKI pivotal trial enrollment SCD platform broader indications
Revenue
$495,000
▲ 68.9% YoY
Gross margin
90.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
SeaStar Medical Holding Corp Q4 FY2025 Earnings Call
Confident tone Pediatric AKI Commercial Expansion (Qualimmune) Neutralize AKI Pivotal Trial Enrollment (Adult AKI) SAVE Registry Publication and Clinical Evidence
Revenue
$420,000*
▲ 526.9% YoY
Gross margin
97.1%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
SeaStar Medical Holding Corp Q3 FY2025 Earnings Call
Confident tone Neutralize AKI pivotal trial enrollment Quellimmune commercial launch and pediatric site activation Neutralize CRS cardiorenal syndrome trial
Revenue
$183,000
▲ 169.1% YoY
Gross margin
92.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
SeaStar Medical Holding Corp Q1 FY2025 Earnings Call
Confident tone QUELIMMUNE pediatric commercial launch NEUTRALIZE-AKI adult pivotal trial Cardiac surgery breakthrough device designations
Revenue
$293,000
Diluted EPS
$-4.40
Gross margin
100.0%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
SeaStar Medical Holding Corp Q4 FY2024 Earnings Call
Revenue
$67,000*
Gross margin
100.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-12-04
SeaStar Medical Holding Corp Q3 FY2024 Earnings Call
Revenue
$68,000
Diluted EPS
$-11.00
Gross margin
100.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-15
SeaStar Medical Holding Corp Q2 FY2023 Earnings Call
Diluted EPS
$-41.00
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 earnings calls
Key facts CIK 1831868 CUSIP 81256L302 13F (30d) 2 filings 2 filers Visit website Investor relations